+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Population Health Management Market Size, Share & Trends Analysis Report by Product (Software, Services), by End Use (Payers, Providers, Employer Groups), by Region (North America, Europe, APAC, Latin America, MEA), and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 120 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 4538830
The global population health management market size is expected to reach USD 280.8 billion by 2030, registering a CAGR of 21.9% over the forecast period. The need for population health services that combine multiple functionalities is increasing due to the complex nature of care delivery and payment models. Population Health Management (PHM) solutions can process clinical, financial, and operational data that help improve efficiency and patient care. The health management program is also witnessing changes in medical reimbursement due to the increasing emphasis on value-based payment models and Accountable Care Organizations (ACOs).



The COVID-19 pandemic has intensified the need for social distance among physicians and other healthcare workers, driving the need for population health management solutions and the correct and timely transmission of patient health information and claims data for patients with chronic diseases. PHM provides effective tools in this regard, including a framework for the secure transmission, sharing, and retrieval of electronic health information and claims data. For clinical and financial decision-making, these technologies enable the smooth transmission and analysis of health-related data between healthcare institutions and patients.

Furthermore, as patient numbers increase, so does the requirement for electronic medical records and electronic health record solutions to manage complicated patient data. Players in this market have also connected the electronic health record platforms with other IT solutions such as population health management and enhanced their software solutions to assist healthcare practitioners in efficiently managing COVID-19 patients. The convenience offered by value-based payment models is responsible for the increased adoption of population health solutions by ACOs.

ACOs, consisting of hospitals, clinics, and other healthcare providers, collaborate with the payers (private and public) to provide high-quality care to the patients. Private and public insurance providers have introduced various disease management programs that help in the treatment of chronic illnesses. These multidisciplinary efforts are expected to result in efficient treatment outcomes and are likely to suggest the best suitable courses of action that need to be undertaken. Successful large-scale trials in the U.S. have enabled significant advancements in disease management programs.

Most healthcare providers worldwide have insufficient infrastructure, including health professionals, patients’ data, technology, and other resources to manage healthcare issues. To manage a large population, suppliers must invest considerably in infrastructure development. The government's expanded monitoring support for healthcare IT systems, as well as the rising use of big data analytics and the need to contain expanding healthcare costs, would all fuel the expansion of the population health management industry.

Population Health Management Market Report Highlights

  • PHM software offers predictive data analytics, which can be applied for interpreting population characteristics from unstructured clinical data.
  • The services product segment held a majority of the market share in 2021, as healthcare providers prefer in-house maintenance services.
  • Healthcare providers held the largest market share of the end-use segment in 2021. The providers can focus effectively on patient-centric care and reducing overall costs. The large market share is attributed to the implementation of the ACA which is the Affordable Care Act for the prevention of diseases, and the adoption of IT in healthcare, this will boost the market growth and create opportunities for the service provider to effectively collect and maintain patients' data.
  • North America was the largest regional market in 2021 and is likely to retain its position over the forecast period, as the providers, payers, providers-payers, and accountable care organizations promote the use of PHM services.
  • In Asia Pacific, the market is expected to witness the fastest growth in the coming years due to rising healthcare expenditure and improving healthcare infrastructure in the region.
  • Acquisitions and business partnerships with other market players are some of the strategic initiatives undertaken by key players to strengthen their market presence.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Population Health Management Market

What is the estimated value of the Global Population Health Management Market?

The Global Population Health Management Market was estimated to be valued at $57.7 Billion in 2022.

What is the growth rate of the Global Population Health Management Market?

The growth rate of the Global Population Health Management Market is 21.9%, with an estimated value of $280.8 Billion by 2030.

What is the forecasted size of the Global Population Health Management Market?

The Global Population Health Management Market is estimated to be worth $280.8 Billion by 2030.

Who are the key companies in the Global Population Health Management Market?

Key companies in the Global Population Health Management Market include Allscripts Healthcare, LLC, Cerner Corporation, Conifer Health Solutions, LLC, eClinicalWorks, Enli Health Intelligence, McKesson Corporation, Medecision, Optum, Inc. and Koninklijke Philips N.V..

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market Driver Analysis
3.1.1.1 Growing demand for value-based healthcare delivery
3.1.1.2 Rising healthcare expenditure across the globe
3.1.1.3 Need for effective disease management across different care settings
3.1.2 Market Restraint Analysis
3.1.2.1 Lack of proper regulatory framework for PHM
3.2 Penetration & Growth Prospects Mapping
3.3 Population Health Management (PHM) Market-PESTLE Analysis
3.4 Industry Analysis-Porter’s
3.5 Population Health Management (PHM) Market: Regulatory Scenario
Chapter 4 Population Health Management (PHM) Market: Product Estimates & Trend Analysis
4.1 Population Health Management (PHM) Market: Product Movement Analysis
4.2 Software
4.2.1 Software Market, 2017-2030 (USD Million)
4.3 Services
4.3.1 Services Market, 2017-2030 (USD Million)
Chapter 5 Population Health Management (PHM) Market: End-use Estimates & Trend Analysis
5.1 Population Health Management (PHM) Market: End-Use Movement Analysis
5.2 Providers
5.2.1 Providers Market, 2017-2030 (USD Million)
5.3 Payers
5.3.1 Payers Market, 2017-2030 (USD Million)
5.4 Employer Groups
5.4.1 Employer Groups Market, 2017-2030 (USD Million)
Chapter 6 Population Health Management (PHM) Market: Regional Estimates & Trend Analysis
6.1 Population Health Management Market Share, by Region
6.2 North America
6.2.1 North America population health management market, 2017-2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. population health management market, 2017-2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada population health management market, 2017-2030 (USD Million)
6.3 Europe
6.3.1 Europe population health management market, 2017-2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. population health management market, 2017-2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany population health management market, 2017-2030 (USD Million)
6.3.4 France
6.3.4.1 France population health management market, 2017-2030 (USD Million)
6.3.5 Italy
6.3.5.1 Italy population health management market, 2017-2030 (USD Million)
6.3.6 Spain
6.3.6.1 Spain population health management market, 2017-2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific population health management market, 2017-2030 (USD Million)
6.4.2 Japan
6.4.2.1 Japan population health management market, 2017-2030 (USD Million)
6.4.3 China
6.4.3.1 China population health management market, 2017-2030 (USD Million)
6.4.4 India
6.4.4.1 India population health management market, 2017-2030 (USD Million)
6.5 Latin America
6.5.1 Latin America population health management market, 2017-2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil population health management market, 2017-2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico population health management market, 2017-2030 (USD Million)
6.6 Middle East & Africa (MEA)
6.6.1 MEA population health management market, 2017-2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa population health management market, 2017-2030 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia population health management market, 2017-2030 (USD Million)
6.6.4 United Arab Emirates (UAE)
6.6.4.1 UAE population health management market, 2017-2030 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Population Health Management Market: Market Position Analysis (Based on Product Portfolio, Strategic Initiatives, Regional Presence, and Recent Updates)
7.3 Company Profiles
7.3.1 Allscripts Healthcare, LLC
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 Cerner Corporation
7.3.2.1 Company Overview
7.3.2.1 Financial Performance
7.3.2.2 Product Benchmarking
7.3.2.3 Strategic Initiatives
7.3.3 Conifer Health Solutions, LLC
7.3.3.1 Company Overview
7.3.3.2 Product Benchmarking
7.3.3.3 Strategic Initiatives
7.3.4 eClinicalWorks
7.3.4.1 Company Overview
7.3.4.2 Product Benchmarking
7.3.5 Enli Health Intelligence
7.3.5.1 Company Overview
7.3.5.2 Product Benchmarking
7.3.5.3 Strategic Initiatives
7.3.6 McKesson Corporation
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic Initiatives
7.3.7 Medecision
7.3.7.1 Company Overview
7.3.7.2 Product Benchmarking
7.3.7.3 Strategic Initiatives
7.3.8 Optum, Inc.
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.9 Advisory Board
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.10 Koninklijke Philips N.V.
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives
7.3.11 Athenahealth, Inc.
7.3.11.1 Company Overview
7.3.11.2 Financial Overview
7.3.11.3 Product Benchmarking
7.3.11.4 Strategic Initiatives
7.3.12 RedBrick Health Corporation
7.3.12.1 Company Overview
7.3.12.2 Product Benchmarking
7.3.12.3 Strategic Initiatives
7.3.13 Welltok
7.3.13.1 Company Overview
7.3.13.2 Product Benchmarking
7.3.13.3 Strategic Initiatives

Companies Mentioned

  • Allscripts Healthcare, LLC
  • Cerner Corporation
  • Conifer Health Solutions, LLC
  • eClinicalWorks
  • Enli Health Intelligence
  • McKesson Corporation
  • Medecision
  • Optum, Inc.
  • Advisory Board
  • Koninklijke Philips N.V.
  • athenahealth, Inc.
  • RedBrick Health Corporation
  • Welltok

Methodology

Loading
LOADING...